China-based dietary supplement manufacturer Sirio Pharma has opened a new gummy production plant in Ma’anshan, China, as it aims to meet increased demand for functional gummies from global markets.
The 26,000 square-metre gummy production plant will form part of the company’s 240,000 square-metre ‘Centre of Excellence’, and will increase Sirio’s gummy production capacity to 2.4 billion gummies per year.
The plant will feature integrated R&D facilities, and will be capable of producing liquid filled, centre-filled, swirled and multi-coloured gummies for customers in the nutraceutical industry.
Rui Yang, chief strategy officer at Sirio Pharma said: “In the US and Europe in particular, there is a significant growth potential in gummy formulations – as they are seen as a more consumer-friendly dosage form.
“For many of the branded firms looking to enter this market early with customised formulations, we offer clear advantages.
“We can expedite development and even offer taste testing options during formulation. Alternatively, we also offer ready-to-go formulations for companies that are looking to enter the market quickly – because we have one of the largest ranges of existing gummy formulations of any global business.
“But as consumers become more discerning, we anticipate branded companies will increasingly need specialist gummy development partners and capabilities.
“The advantage of running an integrated site is that we can develop a much more tailored product for customers, while also expediting development timelines, thanks to a large team of in-house gummy specialists – more than ten scientists and formulation engineers dedicated to gummies.
“We anticipate exponential growth for the gummy lines in 2019. And obviously, with the new capacity we have, we can supply even the largest of nutraceutical brands.”
© FoodBev Media Ltd 2019